Here is a link to the trial:<br><a target="" title="" href="http://clinicaltrials.gov/ct2/show/record/NCT01180634?term=Levofloxacin&recr=Open&rank=8&show_locs=Y">http://clinicaltrials.gov/ct2/show/record/NCT01180634?term=Levofloxacin&recr=Open&rank=8&show_locs=Y</a> It's a phase III, placebo-controlled trial. The med is being administered via eFlow.
<br>
<br>This is exciting. Emily does very well with Levaquin, so if this becomes approved it's very good to know it will be available in a form that may both better target the lungs as well as hopefully?? reduce toxicity to the rest of the body.<br><br>ETA: the other trial comparing Aeroquin to Tobi head to head:<br><a target="" title="" href="http://clinicaltrials.gov/ct2/show/NCT01270347?term=Levofloxacin&recr=Open&rank=12">http://clinicaltrials.gov/ct2/show/NCT01270347?term=Levofloxacin&recr=Open&rank=12</a><br>
<br>
<br>This is exciting. Emily does very well with Levaquin, so if this becomes approved it's very good to know it will be available in a form that may both better target the lungs as well as hopefully?? reduce toxicity to the rest of the body.<br><br>ETA: the other trial comparing Aeroquin to Tobi head to head:<br><a target="" title="" href="http://clinicaltrials.gov/ct2/show/NCT01270347?term=Levofloxacin&recr=Open&rank=12">http://clinicaltrials.gov/ct2/show/NCT01270347?term=Levofloxacin&recr=Open&rank=12</a><br>